Gut Health Products Market

As per Market Research Future Analysis, the Global Gut Health Products Market was valued at USD 51.20 billion in 2024 and is projected to grow from USD 55.12 billion in 2025 to USD 107.03 billion by 2034, with a CAGR of 7.7% during the forecast period. The growth is driven by rising consumer awareness of diet, the strong presence of key players, and increased demand for gut health products. Probiotics dominate the market, accounting for approximately 67-69% of revenue, while organic products are preferred due to health trends. North America holds a significant market share of 32.24%, supported by product innovations and consumer awareness.

Key players include Bayer AG, Nestle SA, BASF, DuPont, Sanofi, Yakult Honsha Co., Ltd., Cie Gervais Danone, Deerland Probiotics & Enzymes, Inc., Chr. Hansen Holding A/S, and Amway Corporation.

March 2023: BASF and Cargill (Provimi) expanded their existing agreement for developing and distributing feed enzymes in South Korea. By utilizing BASF’s strengths in enzyme R&D and Cargill’s expertise in application and extensive market coverage, the partners aim to establish a joint innovation pipeline for animal protein producers in South Korea.

August 2020: OptiBiotix Health announced the extension of the deal with global partners for the distribution of its fiber, mineral lend products, and probiotic supplements. The extension mainly pertains to WellBiome and CholBiome, which address digestive and cardiovascular health, respectively, and are available in the U.S., Germany, Australia, and Asian markets.

October 2020: Sanofi aims to expand its probiotics product portfolio, with the launch of DioraByota to its Dioralyte line of post-diarrhea fluid replacement products.